Bespoke Biotherapeutics is a biotechnology company that provides engineered B-cell therapeutics.
Bespoke Biotherapeutics has raised $256K in total funding. The most recent round was Grant. The last funding was announced in June 2022.
Bespoke Biotherapeutics's investors include National Science Foundation.
Bespoke Biotherapeutics is headquartered in San Mateo, United States.
Bespoke Biotherapeutics is a biotechnology company that provides engineered B-cell therapeutics.
Bespoke Biotherapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bespoke Biotherapeutics — Funding & Investors." VCBacked, June 15, 2022, https://www.vcbacked.co/company/bespoke-biotherapeutics. Accessed September 30, 2026.
VCBacked. (2022). Bespoke Biotherapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/bespoke-biotherapeutics
{{cite web |title=Bespoke Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bespoke-biotherapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated